Z. Cao, E. Sui, and Y. Wu, “Behavior and Consequences of COVID-19-related Voluntary Disclosure: Evidence from Pharmaceutical Companies”, BCPBM, vol. 31, pp. 378–391, Nov. 2022, doi: 10.54691/bcpbm.v31i.2653.